4DMedical Limited
FDMDFOTCHealthcare● Active
$2.66
+$0.00(+0.00%)
Market Cap$1.6B
P/E Ratio—
52W High$5
52W Low$0.16245
4DMedical Limited (FDMDF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FDMDF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($30.07M) | ($35.98M) | ($31.46M) | ($24.59M) | ($21.42M) |
| Depreciation & Amort. | $5.33M | $0.00M | $2.57M | $1.50M | $0.74M |
| Stock-Based Comp. | $2.73M | $0.00M | $1.01M | $0.61M | $1.50M |
| Change in Working Capital | ($10.51M) | $0.70M | $4.80M | ($2.75M) | $4.62M |
| Net Cash from Operations | ($34.48M) | ($30.87M) | ($22.65M) | ($25.27M) | ($14.52M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.09M) | ($0.30M) | ($1.61M) | ($3.08M) | ($0.35M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($1.62M) | ($40.04M) | ($1.61M) | ($3.50M) | ($0.58M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | ($6.38M) |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.97M) | ($1.01M) | $0.17M | ($1.00M) | ($0.53M) |
| Net Cash from Financing | $12.37M | $31.94M | $42.73M | ($1.00M) | $87.55M |
| Free Cash Flow | |||||
| Free Cash Flow | ($34.56M) | ($31.17M) | ($24.27M) | ($28.35M) | ($14.87M) |
| FCF Margin %(computed) | -590.45% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · AUD · M
Explore more 4DMedical Limited data
About 4DMedical Limited (FDMDF) Cash Flow Statement
4DMedical Limited generated operating cash flow of ($0.03B) and free cash flow of ($0.03B) for 2025 — a FCF margin of -590.45%. Capital expenditure was ($0.00B).
Frequently asked questions
FDMDF · 4 questions4DMedical Limited generated free cash flow of ($0.03B) for 2025, down 10.9% year-over-year.
FDMDF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10